ALLMedicine™ Peripheral Neuropathy Center

Mar 17th, 2023 - Diabetic peripheral neuropathy (DPN) is one of the risk factors for foot-related complications among people with type 2 diabetes mellitus (T2DM). Hence, we aimed to validate the Michigan Neuropathy Screening Instrument (MNSI) tool against biothesi...

Mar 17th, 2023 - Peripheral neuropathy (PN) is a common complication in obesity, prediabetes, and type 2 diabetes, though its pathogenesis remains incompletely understood. In a murine high-fat diet (HFD) obesity model of PN, dietary reversal (HFD-R) to a low-fat s...

Mar 15th, 2023 - The aim of this study was to determine the effect of bariatric surgery on diabetes complications in individuals with class II/III obesity (BMI > 35 kg/m2). We performed a prospective cohort study of participants with obesity who underwent bariatri...

Mar 9th, 2023 - Dominant mutations in tyrosyl-tRNA synthetase (YARS1) and six other tRNA ligases cause Charcot-Marie-Tooth peripheral neuropathy (CMT). Loss of aminoacylation is not required for their pathogenicity, suggesting a gain-of-function disease mechanism...

Mar 7th, 2023 - Neuromuscular ultrasound (NMUS) is a valuable tool in establishing a diagnosis of carpal tunnel syndrome (CTS), and can be particularly helpful in patients with clinical CTS but normal nerve conduction studies (NCS). This case involves the uncommo...

Jul 15th, 2020 - To update the ASCO guideline on the recommended prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors. An Expert Panel conducted targeted systematic literature reviews ...

Aug 1st, 2022 - Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed. Key Takeaways In Japanese adults with type 1 diabetes insulin-pump treatment (continuous subcutaneous insulin infusion...

May 4th, 2022 - Key Takeaway Medium to high levels of anxiety increase the risk of chemotherapy-induced peripheral neuropathy (CIPN) in women with breast cancer. Why This Matters CIPN is a common side effect of taxane-based chemotherapy and has negative effects o...

Sep 30th, 2021 - NEW YORK (Reuters Health) - Duloxetine should be a first-line treatment for chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors, according to updated guidelines from the American Society of Clinical Oncology (ASCO). "The mo...

Feb 25th, 2021 - NEW YORK (Reuters Health) - Older patients with low hemoglobin and higher body mass index - particularly women - were more likely to experience chemotherapy-induced peripheral neuropathy (CIPN) in a cohort study. "The identification of these risk ...

Feb 15th, 2021 - Prescriptions for opioids as a first-line treatment for painful diabetic peripheral neuropathy (DPN) outnumbered those for other medications between 2014 and 2018, despite the fact that the former is not recommended, new research indicates. "We kn...